Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Desrosier currently holds 7,623 shares of GENZYME CORP (GENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Desrosier has been a net seller of GENZ stock. They have purchased $0 and sold $1.1M worth of shares.
Thomas Desrosier's most recent insider trade was on Nov 15, 2025, when they sold 76 shares at $17.30 per share.
Thomas Desrosier serves as Executive at GENZYME CORP (GENZ). They have executed 57 insider transactions totaling $1.1M over their tenure at the company.
Thomas Desrosier holds the position of Executive at GENZYME CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Thomas Desrosier has shown a selling trading pattern, with $0 in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Desrosier was on Dec 29, 2014, when they sold $1.2M worth of CBST shares. This transaction involved 11,978 shares at $100.71 per share.
Thomas Desrosier currently owns 7,623 shares of GENZYME CORP (GENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Desrosier's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Desrosier has 57 Form 4 filings on record as an insider at GENZYME CORP.
Set alerts for Thomas Desrosier and 40,000+ other insiders.